In this conversation, Dr. Gladden and Aubrey de Grey discuss the rapid advancements in the field of longevity research, emphasizing the importance of a systems biology approach to understanding aging. They explore the uneven distribution of funding and interest in various areas of research, the role of basic science, and the potential of stem cell therapies. The discussion highlights the need for a comprehensive strategy in addressing aging and the promising results from recent mouse trials. In this conversation, Aubrey de Grey discusses innovative approaches to senolytics and therapeutic combinations aimed at extending human lifespan. He emphasizes the importance of funding and research priorities in longevity, the role of AI in aging research, and the need to mobilize society against aging, drawing parallels to the COVID-19 pandemic. De Grey also elaborates on the hallmarks of aging and their implications for future research, while sharing his personal longevity strategies and practices.
For Audience
Join the other 20,000+ high-performers getting weekly insights on biological reversal, exponential strategies, and Life Energy optimization→ https://start.gladdenlongevity.com/subscribe
If you're ready to measure your 60+ biological ages and build a personalized reversal plan, apply for a discovery call here → https://start.gladdenlongevity.com/apply-now
Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/!
Takeaways
· The longevity field is advancing rapidly with increased funding.
· Interest in aging research is unevenly distributed.
· A systems biology approach is essential for understanding aging.
· Basic science is critical for developing effective interventions.
· Stem cell therapies show promise in treating age-related diseases.
· Rejuvenation should be viewed as an ongoing process.
· Combining multiple interventions may yield better results.
· Personalization of treatments is crucial for effectiveness.
· Understanding the body's responses can lead to better outcomes.
· Future trials will explore a wider range of interventions. We're using a vitaclax that is no longer toxic to platelets.
· The new senolytic from Rockfish Bio shows promising results.
· Our choices are focused on maximizing knowledge per dollar.
· There's a lack of funding for comprehensive aging studies.
· AI can provide insights but cannot replace clinical trials.
· Mobilizing society is crucial to take aging seriously.
· The hallmarks of aging classify downstream effects of damage.
· Repairing damage is more effective than understanding its mechanisms.
· Maintaining youthfulness is an ongoing process.
· Regular health check-ups can identify personal weak links.
Chapters
00:00 The Current State of Longevity Research
02:50 The Systems Biology Approach to Aging
06:02 Understanding Aging: A Systems Perspective
08:56 The Role of Basic Science in Longevity
11:58 Interventions in Aging: Current Progress
14:56 The Future of Stem Cell Therapies
18:08 Rejuvenation as a Process
21:01 The Divide and Conquer Strategy in Aging Research
23:52 The Next Steps in Mouse Trials
29:15 Innovative Approaches to Senolytics
31:02 Exploring New Therapeutic Combinations
32:36 Funding and Research Priorities in Longevity
33:09 The Role of AI in Aging Research
34:28 Mobilizing Society Against Aging
39:26 The Hallmarks of Aging and Their Implications
51:12 Personal Longevity Strategies and Practices
To learn more about Dr. Aubrey De Grey:
Website: https://www.levf.org/
Reach out to us at:
Website: https://gladdenlongevity.com/
Facebook: https://www.facebook.com/Gladdenlongevity/
Instagram: https://www.instagram.com/gladdenlongevity/?hl=en
LinkedIn: https://www.linkedin.com/company/gladdenlongevity
YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw
